Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
ZJYL

Market Cap: $16.2M

JL

Jin Medical International Ltd.

ZJYL

NASDAQ (NASDAQ Capital Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin30.62%

EBITDA Margin3.63%

EBIT Margin2.12%

Pre-tax Margin6.40%

Net Profit Margin5.94%

Earnings Yield7.24%

Valuation Multiples

Price / Book0.53

Price / Sales0.82

Price / Earnings14.16

PEG-0.41

Forward PEG-0.41

EV / Sales1.40

EV / EBITDA38.63

EV / Operating Cash Flow-46.72

EV / Free Cash Flow-3.98

Price / Free Cash Flow-2.33

Price / Operating Cash Flow-27.33

Cash Flow & Capital

Free Cash Flow / Share-$0.89

Operating Cash Flow / Share-$0.08

Free Cash Flow Yield-42.95%

Capex / Revenue32.27%

Capex / Operating Cash Flow-10.74%

Capex / Depreciation21.29

Stock Compensation / Revenue0.00%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.95

Quick Ratio1.64

Cash Ratio0.40

Debt / Assets0.37

Debt / Capital0.40

Debt / Equity0.68

Long-Term Debt / Capital0.09

Debt / Market Cap1.27%

Net Debt / EBITDA16.03

Solvency Ratio0.06

Financial Leverage1.84

Efficiency & Working Capital

Asset Turnover0.35

Fixed Asset Turnover1.99

Inventory Turnover1.92

Receivables Turnover2.97

Payables Turnover5.26

Days Sales Outstanding123.02

Days Inventory Outstanding189.89

Days Payables Outstanding69.43

Operating Cycle312.91

Cash Conversion Cycle243.47

Working Capital Turnover0.94

Returns & Quality

Return on Equity3.91%

Return on Assets2.10%

Return on Invested Capital0.76%

ROCE1.27%

Return on Tangible Assets2.10%

Operating Return on Assets0.77%

Income Quality-0.51

Tax Burden0.93

Interest Burden3.02

Balance Sheet & Intrinsic Metrics

Enterprise Value$27.7M

Invested Capital$31.53M

Working Capital$21.63M

Tangible Asset Value$30.15M

Net Current Asset Value$18.76M

Graham Number$3.61

Graham Net-Net$1.66

Book Value / Share$3.85

Tangible Book Value / Share$3.85

Cash / Share$3.85

Financial Health Scores

Piotroski Score3

Altman Z-Score2.27

Revenue$42.55M

EBIT$2.37M

Market Cap$16.16M

Working Capital$21.63M

Retained Earnings$20.83M

Total Assets$55.84M

Total Liabilities$25.69M